TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer

Ming Chi(State Key Laboratory of New Ceramics and Fine Processing), Biao Wang(The Central Hospital of Xiao gan)

Journal of Experimental & Clinical Cancer Research

May 17, 2022

10.1186/s13046-022-02377-3

Cited by 164

Related Papers

Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells

|Journal of Experimental & Clinical Cancer Research|2019|104